ARMP Armata Pharmaceuticals, Inc.

Develops and commercializes novel bacteriophage-based therapeutics

As of 07/23/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/20/2015
Outstanding shares:  24,940,442
Average volume:  10,691
Market cap:   $99,761,768
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    04216R102
ISIN:        US04216R1023
Sedol:      BH3T9X8
Valuation   (See tab for details)
PE ratio:   -5.83
PB ratio:   2.93
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy